Herbert Irving Cancer Center, New York
Hyperosmolar mannitol evaluated as a liquid tumor embolization agent
Published in Surgery Litigation and Law Weekly, August 12th, 2005
"This study assesses the cytotoxicity of hyperosmolar mannitol on human endothelial and meningioma cells in vitro and summarizes the initial clinical experience of using mannitol as a liquid tumor embolization agent. Human umbilical vein endothelial cells and primary meningioma cells from surgical specimens were treated with 300, 600, 900, and 1200 mOsm of mannitol, mannitol and iohexol mixture, saline, and iohexol alone," researchers in the United States reported.
"Cell death was evaluated with a Live/Dead kit and quantified with thymidine...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- American Heart Association
AHA publishes statement on infective endocarditis - Castle Hill Hospital, Humberside
Bcl-2 expression predicts radiotherapy failure in laryngeal cancer - Novadaq Technologies Inc.
Patent issued for SPY Intra-operative Imaging System - Oncura
CMS adds cryosurgical ablation of prostate to Medicare covered procedures list - Sanjukai Hospital, Hokkaido
"100-minute" retroperitoneal radical nephrectomy method devised - Wakefield Clinic, Adelaide
Basosquamous carcinoma treated with Mohs micrographic surgery - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
